APO Research, Inc.

APO RESEARCH · REPORT

Sotalol

Selected research

Market Analysis & Forecast

Global Sotalol Market Analysis and Forecast 2026-2032

Market perspective

The global Sotalol market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Sotalol is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Sotalol is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Sotalol is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Sotalol is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Sotalol include Shaanxi Hanjiang Pharmaceutical Group, GSK, Bayer, Samarth Pharma Pvt. Ltd., Cipla Limited, Cambrex, Bristol-Myers Squibb (BMS), Arevipharma and Arbor Pharmaceuticals, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Sotalol, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Sotalol, also provides the sales of main regions and countries. Of the upcoming market potential for Sotalol, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Sotalol sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Sotalol market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Sotalol sales, projected growth trends, production technology, application and end-user industry.

Sotalol Segment by Company

Shaanxi Hanjiang Pharmaceutical Group

GSK

Bayer

Samarth Pharma Pvt. Ltd.

Cipla Limited

Cambrex

Bristol-Myers Squibb (BMS)

Arevipharma

Arbor Pharmaceuticals

Sotalol Segment by Type

40mg Sotalol

80mg Sotalol

Sotalol Segment by Application

Sustained Ventricular Tachycardia

Atrial Fibrillation/Flutter

Sotalol Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Sotalol market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Sotalol and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Sotalol.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Sotalol in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Sotalol manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Sotalol sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Sotalol Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. 40mg Sotalol Major Manufacturers Table 3. 80mg Sotalol Major Manufacturers Table 4. Global Sotalol Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Sustained Ventricular Tachycardia Major Manufacturers Table 6. Atrial Fibrillation/Flutter Major Manufacturers Table 7. Sotalol Industry Trends Table 8. Sotalol Industry Drivers Table 9. Sotalol Industry Opportunities and Challenges Table 10. Sotalol Industry Restraints Table 11. Global Sotalol Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 12. Global Sotalol Revenue by Region (2021-2026) & (US$ Million) Table 13. Global Sotalol Revenue by Region (2027-2032) & (US$ Million) Table 14. Global Sotalol Revenue Market Share by Region (2021-2026) Table 15. Global Sotalol Revenue Market Share by Region (2027-2032) Table 16. Global Sotalol Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (m units) Table 17. Global Sotalol Sales by Region (2021-2026) & (m units) Table 18. Global Sotalol Sales by Region (2027-2032) & (m units) Table 19. Global Sotalol Sales Market Share by Region (2021-2026) Table 20. Global Sotalol Sales Market Share by Region (2027-2032) Table 21. Global Sotalol Revenue by Manufacturers (US$ Million) & (2021-2026) Table 22. Global Sotalol Revenue Market Share by Manufacturers (2021-2026) Table 23. Global Sotalol Sales by Manufacturers (US$ Million) & (2021-2026) Table 24. Global Sotalol Sales Market Share by Manufacturers (2021-2026) Table 25. Global Sotalol Sales Price (US$/k unit) of Manufacturers (2021-2026) Table 26. Global Sotalol Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 27. Global Sotalol Key Manufacturers Manufacturing Sites & Headquarters Table 28. Global Sotalol Manufacturers, Product Type & Application Table 29. Global Sotalol Manufacturers' Establishment Date Table 30. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 31. Global Sotalol by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 32. Global Sotalol Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 33. Global Sotalol Revenue by Type (2021-2026) & (US$ Million) Table 34. Global Sotalol Revenue by Type (2027-2032) & (US$ Million) Table 35. Global Sotalol Revenue Market Share by Type (2021-2026) Table 36. Global Sotalol Revenue Market Share by Type (2027-2032) Table 37. Global Sotalol Sales by Type 2021 VS 2025 VS 2032 (m units) Table 38. Global Sotalol Sales by Type (2021-2026) & (m units) Table 39. Global Sotalol Sales by Type (2027-2032) & (m units) Table 40. Global Sotalol Sales Market Share by Type (2021-2026) Table 41. Global Sotalol Sales Market Share by Type (2027-2032) Table 42. Global Sotalol Price by Type (2021-2026) & (US$/k unit) Table 43. Global Sotalol Price by Type (2027-2032) & (US$/k unit) Table 44. Global Sotalol Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 45. Global Sotalol Revenue by Application (2021-2026) & (US$ Million) Table 46. Global Sotalol Revenue by Application (2027-2032) & (US$ Million) Table 47. Global Sotalol Revenue Market Share by Application (2021-2026) Table 48. Global Sotalol Revenue Market Share by Application (2027-2032) Table 49. Global Sotalol Sales by Application 2021 VS 2025 VS 2032 (m units) Table 50. Global Sotalol Sales by Application (2021-2026) & (m units) Table 51. Global Sotalol Sales by Application (2027-2032) & (m units) Table 52. Global Sotalol Sales Market Share by Application (2021-2026) Table 53. Global Sotalol Sales Market Share by Application (2027-2032) Table 54. Global Sotalol Price by Application (2021-2026) & (US$/k unit) Table 55. Global Sotalol Price by Application (2027-2032) & (US$/k unit) Table 56. Shaanxi Hanjiang Pharmaceutical Group Company Information Table 57. Shaanxi Hanjiang Pharmaceutical Group Business Overview Table 58. Shaanxi Hanjiang Pharmaceutical Group Sotalol Sales (m units), Revenue (US$ Million), Price (US$/k unit) and Gross Margin (2021-2026) Table 59. Shaanxi Hanjiang Pharmaceutical Group Sotalol Product Portfolio Table 60. Shaanxi Hanjiang Pharmaceutical Group Recent Development Table 61. GSK Company Information Table 62. GSK Business Overview Table 63. GSK Sotalol Sales (m units), Revenue (US$ Million), Price (US$/k unit) and Gross Margin (2021-2026) Table 64. GSK Sotalol Product Portfolio Table 65. GSK Recent Development Table 66. Bayer Company Information Table 67. Bayer Business Overview Table 68. Bayer Sotalol Sales (m units), Revenue (US$ Million), Price (US$/k unit) and Gross Margin (2021-2026) Table 69. Bayer Sotalol Product Portfolio Table 70. Bayer Recent Development Table 71. Samarth Pharma Pvt. Ltd. Company Information Table 72. Samarth Pharma Pvt. Ltd. Business Overview Table 73. Samarth Pharma Pvt. Ltd. Sotalol Sales (m units), Revenue (US$ Million), Price (US$/k unit) and Gross Margin (2021-2026) Table 74. Samarth Pharma Pvt. Ltd. Sotalol Product Portfolio Table 75. Samarth Pharma Pvt. Ltd. Recent Development Table 76. Cipla Limited Company Information Table 77. Cipla Limited Business Overview Table 78. Cipla Limited Sotalol Sales (m units), Revenue (US$ Million), Price (US$/k unit) and Gross Margin (2021-2026) Table 79. Cipla Limited Sotalol Product Portfolio Table 80. Cipla Limited Recent Development Table 81. Cambrex Company Information Table 82. Cambrex Business Overview Table 83. Cambrex Sotalol Sales (m units), Revenue (US$ Million), Price (US$/k unit) and Gross Margin (2021-2026) Table 84. Cambrex Sotalol Product Portfolio Table 85. Cambrex Recent Development Table 86. Bristol-Myers Squibb (BMS) Company Information Table 87. Bristol-Myers Squibb (BMS) Business Overview Table 88. Bristol-Myers Squibb (BMS) Sotalol Sales (m units), Revenue (US$ Million), Price (US$/k unit) and Gross Margin (2021-2026) Table 89. Bristol-Myers Squibb (BMS) Sotalol Product Portfolio Table 90. Bristol-Myers Squibb (BMS) Recent Development Table 91. Arevipharma Company Information Table 92. Arevipharma Business Overview Table 93. Arevipharma Sotalol Sales (m units), Revenue (US$ Million), Price (US$/k unit) and Gross Margin (2021-2026) Table 94. Arevipharma Sotalol Product Portfolio Table 95. Arevipharma Recent Development Table 96. Arbor Pharmaceuticals Company Information Table 97. Arbor Pharmaceuticals Business Overview Table 98. Arbor Pharmaceuticals Sotalol Sales (m units), Revenue (US$ Million), Price (US$/k unit) and Gross Margin (2021-2026) Table 99. Arbor Pharmaceuticals Sotalol Product Portfolio Table 100. Arbor Pharmaceuticals Recent Development Table 101. North America Sotalol Revenue by Type (2021-2026) & (US$ Million) Table 102. North America Sotalol Revenue by Type (2027-2032) & (US$ Million) Table 103. North America Sotalol Sales by Type (2021-2026) & (m units) Table 104. North America Sotalol Sales by Type (2027-2032) & (m units) Table 105. North America Sotalol Sales Price by Type (2021-2026) & (US$/k unit) Table 106. North America Sotalol Sales Price by Type (2027-2032) & (US$/k unit) Table 107. North America Sotalol Revenue by Application (2021-2026) & (US$ Million) Table 108. North America Sotalol Revenue by Application (2027-2032) & (US$ Million) Table 109. North America Sotalol Sales by Application (2021-2026) & (m units) Table 110. North America Sotalol Sales by Application (2027-2032) & (m units) Table 111. North America Sotalol Sales Price by Application (2021-2026) & (US$/k unit) Table 112. North America Sotalol Sales Price by Application (2027-2032) & (US$/k unit) Table 113. North America Sotalol Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 114. North America Sotalol Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 115. North America Sotalol Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 116. North America Sotalol Sales by Country (2021 VS 2025 VS 2032) & (m units) Table 117. North America Sotalol Sales by Country (2021-2026) & (m units) Table 118. North America Sotalol Sales by Country (2027-2032) & (m units) Table 119. North America Sotalol Sales Price by Country (2021-2026) & (US$/k unit) Table 120. North America Sotalol Sales Price by Country (2027-2032) & (US$/k unit) Table 121. United States Sotalol Revenue (2021-2032) & (US$ Million) Table 122. Canada Sotalol Revenue (2021-2032) & (US$ Million) Table 123. Mexico Sotalol Revenue (2021-2032) & (US$ Million) Table 124. Europe Sotalol Revenue by Type (2021-2026) & (US$ Million) Table 125. Europe Sotalol Revenue by Type (2027-2032) & (US$ Million) Table 126. Europe Sotalol Sales by Type (2021-2026) & (m units) Table 127. Europe Sotalol Sales by Type (2027-2032) & (m units) Table 128. Europe Sotalol Sales Price by Type (2021-2026) & (US$/k unit) Table 129. Europe Sotalol Sales Price by Type (2027-2032) & (US$/k unit) Table 130. Europe Sotalol Revenue by Application (2021-2026) & (US$ Million) Table 131. Europe Sotalol Revenue by Application (2027-2032) & (US$ Million) Table 132. Europe Sotalol Sales by Application (2021-2026) & (m units) Table 133. Europe Sotalol Sales by Application (2027-2032) & (m units) Table 134. Europe Sotalol Sales Price by Application (2021-2026) & (US$/k unit) Table 135. Europe Sotalol Sales Price by Application (2027-2032) & (US$/k unit) Table 136. Europe Sotalol Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 137. Europe Sotalol Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 138. Europe Sotalol Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 139. Europe Sotalol Sales by Country (2021 VS 2025 VS 2032) & (m units) Table 140. Europe Sotalol Sales by Country (2021-2026) & (m units) Table 141. Europe Sotalol Sales by Country (2027-2032) & (m units) Table 142. Europe Sotalol Sales Price by Country (2021-2026) & (US$/k unit) Table 143. Europe Sotalol Sales Price by Country (2027-2032) & (US$/k unit) Table 144. Germany Sotalol Revenue (2021-2032) & (US$ Million) Table 145. France Sotalol Revenue (2021-2032) & (US$ Million) Table 146. U.K. Sotalol Revenue (2021-2032) & (US$ Million) Table 147. Italy Sotalol Revenue (2021-2032) & (US$ Million) Table 148. Russia Sotalol Revenue (2021-2032) & (US$ Million) Table 149. Spain Sotalol Revenue (2021-2032) & (US$ Million) Table 150. Netherlands Sotalol Revenue (2021-2032) & (US$ Million) Table 151. Switzerland Sotalol Revenue (2021-2032) & (US$ Million) Table 152. Sweden Sotalol Revenue (2021-2032) & (US$ Million) Table 153. Poland Sotalol Revenue (2021-2032) & (US$ Million) Table 154. China Sotalol Revenue by Type (2021-2026) & (US$ Million) Table 155. China Sotalol Revenue by Type (2027-2032) & (US$ Million) Table 156. China Sotalol Sales by Type (2021-2026) & (m units) Table 157. China Sotalol Sales by Type (2027-2032) & (m units) Table 158. China Sotalol Sales Price by Type (2021-2026) & (US$/k unit) Table 159. China Sotalol Sales Price by Type (2027-2032) & (US$/k unit) Table 160. China Sotalol Revenue by Application (2021-2026) & (US$ Million) Table 161. China Sotalol Revenue by Application (2027-2032) & (US$ Million) Table 162. China Sotalol Sales by Application (2021-2026) & (m units) Table 163. China Sotalol Sales by Application (2027-2032) & (m units) Table 164. China Sotalol Sales Price by Application (2021-2026) & (US$/k unit) Table 165. China Sotalol Sales Price by Application (2027-2032) & (US$/k unit) Table 166. Asia Sotalol Revenue by Type (2021-2026) & (US$ Million) Table 167. Asia Sotalol Revenue by Type (2027-2032) & (US$ Million) Table 168. Asia Sotalol Sales by Type (2021-2026) & (m units) Table 169. Asia Sotalol Sales by Type (2027-2032) & (m units) Table 170. Asia Sotalol Sales Price by Type (2021-2026) & (US$/k unit) Table 171. Asia Sotalol Sales Price by Type (2027-2032) & (US$/k unit) Table 172. Asia Sotalol Revenue by Application (2021-2026) & (US$ Million) Table 173. Asia Sotalol Revenue by Application (2027-2032) & (US$ Million) Table 174. Asia Sotalol Sales by Application (2021-2026) & (m units) Table 175. Asia Sotalol Sales by Application (2027-2032) & (m units) Table 176. Asia Sotalol Sales Price by Application (2021-2026) & (US$/k unit) Table 177. Asia Sotalol Sales Price by Application (2027-2032) & (US$/k unit) Table 178. Asia Sotalol Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 179. Asia Sotalol Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 180. Asia Sotalol Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 181. Asia Sotalol Sales by Country (2021 VS 2025 VS 2032) & (m units) Table 182. Asia Sotalol Sales by Country (2021-2026) & (m units) Table 183. Asia Sotalol Sales by Country (2027-2032) & (m units) Table 184. Asia Sotalol Sales Price by Country (2021-2026) & (US$/k unit) Table 185. Asia Sotalol Sales Price by Country (2027-2032) & (US$/k unit) Table 186. Japan Sotalol Revenue (2021-2032) & (US$ Million) Table 187. South Korea Sotalol Revenue (2021-2032) & (US$ Million) Table 188. India Sotalol Revenue (2021-2032) & (US$ Million) Table 189. Australia Sotalol Revenue (2021-2032) & (US$ Million) Table 190. Taiwan Sotalol Revenue (2021-2032) & (US$ Million) Table 191. Southeast Asia Sotalol Revenue (2021-2032) & (US$ Million) Table 192. SAMEA Sotalol Revenue by Type (2021-2026) & (US$ Million) Table 193. SAMEA Sotalol Revenue by Type (2027-2032) & (US$ Million) Table 194. SAMEA Sotalol Sales by Type (2021-2026) & (m units) Table 195. SAMEA Sotalol Sales by Type (2027-2032) & (m units) Table 196. SAMEA Sotalol Sales Price by Type (2021-2026) & (US$/k unit) Table 197. SAMEA Sotalol Sales Price by Type (2027-2032) & (US$/k unit) Table 198. SAMEA Sotalol Revenue by Application (2021-2026) & (US$ Million) Table 199. SAMEA Sotalol Revenue by Application (2027-2032) & (US$ Million) Table 200. SAMEA Sotalol Sales by Application (2021-2026) & (m units) Table 201. SAMEA Sotalol Sales by Application (2027-2032) & (m units) Table 202. SAMEA Sotalol Sales Price by Application (2021-2026) & (US$/k unit) Table 203. SAMEA Sotalol Sales Price by Application (2027-2032) & (US$/k unit) Table 204. SAMEA Sotalol Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 205. SAMEA Sotalol Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 206. SAMEA Sotalol Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 207. SAMEA Sotalol Sales by Country (2021 VS 2025 VS 2032) & (m units) Table 208. SAMEA Sotalol Sales by Country (2021-2026) & (m units) Table 209. SAMEA Sotalol Sales by Country (2027-2032) & (m units) Table 210. SAMEA Sotalol Sales Price by Country (2021-2026) & (US$/k unit) Table 211. SAMEA Sotalol Sales Price by Country (2027-2032) & (US$/k unit) Table 212. Brazil Sotalol Revenue (2021-2032) & (US$ Million) Table 213. Argentina Sotalol Revenue (2021-2032) & (US$ Million) Table 214. Chile Sotalol Revenue (2021-2032) & (US$ Million) Table 215. Colombia Sotalol Revenue (2021-2032) & (US$ Million) Table 216. Peru Sotalol Revenue (2021-2032) & (US$ Million) Table 217. Saudi Arabia Sotalol Revenue (2021-2032) & (US$ Million) Table 218. Israel Sotalol Revenue (2021-2032) & (US$ Million) Table 219. UAE Sotalol Revenue (2021-2032) & (US$ Million) Table 220. Turkey Sotalol Revenue (2021-2032) & (US$ Million) Table 221. Iran Sotalol Revenue (2021-2032) & (US$ Million) Table 222. Egypt Sotalol Revenue (2021-2032) & (US$ Million) Table 223. Key Raw Materials Table 224. Raw Materials Key Suppliers Table 225. Sotalol Distributors List Table 226. Sotalol Customers List Table 227. Research Programs/Design for This Report Table 228. Authors List of This Report Table 229. Secondary Sources Table 230. Primary Sources List of Figures Figure 1. Sotalol Image Figure 2. Global Sotalol Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Sotalol Market Size Share 2021 VS 2025 VS 2032 Figure 4. 40mg Sotalol Image Figure 5. 80mg Sotalol Image Figure 6. Global Sotalol Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Sotalol Market Size Share 2021 VS 2025 VS 2032 Figure 8. Sustained Ventricular Tachycardia Image Figure 9. Atrial Fibrillation/Flutter Image Figure 10. Global Sotalol Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 11. Global Sotalol Revenue (2021-2032) & (US$ Million) Figure 12. Global Sotalol Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 13. Global Sotalol Revenue Market Share by Region: 2025 Versus 2032 Figure 14. Global Sotalol Revenue Market Share by Region (2021-2032) Figure 15. Global Sotalol Sales (2021-2032) & (m units) Figure 16. Global Sotalol Sales by Region: 2021 VS 2025 VS 2032 (m units) Figure 17. Global Sotalol Sales Market Share by Region (2021-2032) Figure 18. US & Canada & Mexico Sotalol Sales YoY (2021-2032) & (m units) Figure 19. Europe Sotalol Sales YoY (2021-2032) & (m units) Figure 20. China Sotalol Sales YoY (2021-2032) & (m units) Figure 21. Asia (Excluding China) Sotalol Sales YoY (2021-2032) & (m units) Figure 22. South America, Middle East and Africa Sotalol Sales YoY (2021-2032) & (m units) Figure 23. Global Sotalol Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 24. Global Sotalol Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 25. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 26. Global Sotalol Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 27. Global Sotalol Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 28. Global Sotalol Revenue Market Share by Type (2021-2032) Figure 29. Global Sotalol Sales by Type (2021 VS 2025 VS 2032) & (m units) Figure 30. Global Sotalol Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 31. Global Sotalol Sales Market Share by Type (2021-2032) Figure 32. Global Sotalol Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 33. Global Sotalol Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 34. Global Sotalol Revenue Market Share by Application (2021-2032) Figure 35. Global Sotalol Sales by Application (2021 VS 2025 VS 2032) & (m units) Figure 36. Global Sotalol Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 37. Global Sotalol Sales Market Share by Application (2021-2032) Figure 38. North America Sotalol Revenue Share by Type (2021-2032) Figure 39. North America Sotalol Sales Share by Type (2021-2032) Figure 40. North America Sotalol Revenue Share by Application (2021-2032) Figure 41. North America Sotalol Sales Share by Application (2021-2032) Figure 42. North America Sotalol Revenue Share by Country (2021-2032) Figure 43. North America Sotalol Sales Share by Country (2021-2032) Figure 44. Europe Sotalol Revenue Share by Type (2021-2032) Figure 45. Europe Sotalol Sales Share by Type (2021-2032) Figure 46. Europe Sotalol Revenue Share by Application (2021-2032) Figure 47. Europe Sotalol Sales Share by Application (2021-2032) Figure 48. Europe Sotalol Revenue Share by Country (2021-2032) Figure 49. Europe Sotalol Sales Share by Country (2021-2032) Figure 50. China Sotalol Revenue Share by Type (2021-2032) Figure 51. China Sotalol Sales Share by Type (2021-2032) Figure 52. China Sotalol Revenue Share by Application (2021-2032) Figure 53. China Sotalol Sales Share by Application (2021-2032) Figure 54. Asia Sotalol Revenue Share by Type (2021-2032) Figure 55. Asia Sotalol Sales Share by Type (2021-2032) Figure 56. Asia Sotalol Revenue Share by Application (2021-2032) Figure 57. Asia Sotalol Sales Share by Application (2021-2032) Figure 58. Asia Sotalol Revenue Share by Country (2021-2032) Figure 59. Asia Sotalol Sales Share by Country (2021-2032) Figure 60. SAMEA Sotalol Revenue Share by Type (2021-2032) Figure 61. SAMEA Sotalol Sales Share by Type (2021-2032) Figure 62. SAMEA Sotalol Revenue Share by Application (2021-2032) Figure 63. SAMEA Sotalol Sales Share by Application (2021-2032) Figure 64. SAMEA Sotalol Revenue Share by Country (2021-2032) Figure 65. SAMEA Sotalol Sales Share by Country (2021-2032) Figure 66. Sotalol Value Chain Figure 67. Manufacturing Cost Structure Figure 68. Sotalol Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • 40mg Sotalol
  • 80mg Sotalol
Applications
  • Sustained Ventricular Tachycardia
  • Atrial Fibrillation/Flutter
Companies covered
  • Shaanxi Hanjiang Pharmaceutical Group
  • GSK
  • Bayer
  • Samarth Pharma Pvt. Ltd.
  • Cipla Limited
  • Cambrex
  • Bristol-Myers Squibb (BMS)
  • Arevipharma
  • Arbor Pharmaceuticals

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Sotalol Market by Type
  3. 1.2.1 Global Sotalol Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 40mg Sotalol
  5. 1.2.3 80mg Sotalol
  6. 1.3 Sotalol Market by Application
  7. 1.3.1 Global Sotalol Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Sustained Ventricular Tachycardia
  9. 1.3.3 Atrial Fibrillation/Flutter
  10. 1.4 Assumptions and Limitations
  11. 1.5 Study Goals and Objectives
2 Sotalol Market Dynamics
  1. 2.1 Sotalol Industry Trends
  2. 2.2 Sotalol Industry Drivers
  3. 2.3 Sotalol Industry Opportunities and Challenges
  4. 2.4 Sotalol Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Sotalol Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Sotalol Revenue by Region
  3. 3.2.1 Global Sotalol Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Sotalol Revenue by Region (2021-2026)
  5. 3.2.3 Global Sotalol Revenue by Region (2027-2032)
  6. 3.2.4 Global Sotalol Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Sotalol Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Sotalol Sales by Region
  9. 3.4.1 Global Sotalol Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Sotalol Sales by Region (2021-2026)
  11. 3.4.3 Global Sotalol Sales by Region (2027-2032)
  12. 3.4.4 Global Sotalol Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Sotalol Revenue by Manufacturers
  2. 4.1.1 Global Sotalol Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Sotalol Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Sotalol Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Sotalol Sales by Manufacturers
  6. 4.2.1 Global Sotalol Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Sotalol Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Sotalol Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Sotalol Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Sotalol Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Sotalol Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Sotalol Manufacturers, Product Type & Application
  13. 4.7 Global Sotalol Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Sotalol Market CR5 and HHI
  16. 4.8.2 2025 Sotalol Tier 1, Tier 2, and Tier 3
5 Sotalol Market by Type
  1. 5.1 Global Sotalol Revenue by Type
  2. 5.1.1 Global Sotalol Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Sotalol Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Sotalol Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Sotalol Sales by Type
  6. 5.2.1 Global Sotalol Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Sotalol Sales by Type (2021-2032) & (m units)
  8. 5.2.3 Global Sotalol Sales Market Share by Type (2021-2032)
  9. 5.3 Global Sotalol Price by Type
6 Sotalol Market by Application
  1. 6.1 Global Sotalol Revenue by Application
  2. 6.1.1 Global Sotalol Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Sotalol Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Sotalol Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Sotalol Sales by Application
  6. 6.2.1 Global Sotalol Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Sotalol Sales by Application (2021-2032) & (m units)
  8. 6.2.3 Global Sotalol Sales Market Share by Application (2021-2032)
  9. 6.3 Global Sotalol Price by Application
7 Company Profiles
  1. 7.1 Shaanxi Hanjiang Pharmaceutical Group
  2. 7.1.1 Shaanxi Hanjiang Pharmaceutical Group Company Information
  3. 7.1.2 Shaanxi Hanjiang Pharmaceutical Group Business Overview
  4. 7.1.3 Shaanxi Hanjiang Pharmaceutical Group Sotalol Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Shaanxi Hanjiang Pharmaceutical Group Sotalol Product Portfolio
  6. 7.1.5 Shaanxi Hanjiang Pharmaceutical Group Recent Developments
  7. 7.2 GSK
  8. 7.2.1 GSK Company Information
  9. 7.2.2 GSK Business Overview
  10. 7.2.3 GSK Sotalol Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 GSK Sotalol Product Portfolio
  12. 7.2.5 GSK Recent Developments
  13. 7.3 Bayer
  14. 7.3.1 Bayer Company Information
  15. 7.3.2 Bayer Business Overview
  16. 7.3.3 Bayer Sotalol Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Bayer Sotalol Product Portfolio
  18. 7.3.5 Bayer Recent Developments
  19. 7.4 Samarth Pharma Pvt. Ltd.
  20. 7.4.1 Samarth Pharma Pvt. Ltd. Company Information
  21. 7.4.2 Samarth Pharma Pvt. Ltd. Business Overview
  22. 7.4.3 Samarth Pharma Pvt. Ltd. Sotalol Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Samarth Pharma Pvt. Ltd. Sotalol Product Portfolio
  24. 7.4.5 Samarth Pharma Pvt. Ltd. Recent Developments
  25. 7.5 Cipla Limited
  26. 7.5.1 Cipla Limited Company Information
  27. 7.5.2 Cipla Limited Business Overview
  28. 7.5.3 Cipla Limited Sotalol Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Cipla Limited Sotalol Product Portfolio
  30. 7.5.5 Cipla Limited Recent Developments
  31. 7.6 Cambrex
  32. 7.6.1 Cambrex Company Information
  33. 7.6.2 Cambrex Business Overview
  34. 7.6.3 Cambrex Sotalol Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Cambrex Sotalol Product Portfolio
  36. 7.6.5 Cambrex Recent Developments
  37. 7.7 Bristol-Myers Squibb (BMS)
  38. 7.7.1 Bristol-Myers Squibb (BMS) Company Information
  39. 7.7.2 Bristol-Myers Squibb (BMS) Business Overview
  40. 7.7.3 Bristol-Myers Squibb (BMS) Sotalol Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 Bristol-Myers Squibb (BMS) Sotalol Product Portfolio
  42. 7.7.5 Bristol-Myers Squibb (BMS) Recent Developments
  43. 7.8 Arevipharma
  44. 7.8.1 Arevipharma Company Information
  45. 7.8.2 Arevipharma Business Overview
  46. 7.8.3 Arevipharma Sotalol Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 Arevipharma Sotalol Product Portfolio
  48. 7.8.5 Arevipharma Recent Developments
  49. 7.9 Arbor Pharmaceuticals
  50. 7.9.1 Arbor Pharmaceuticals Company Information
  51. 7.9.2 Arbor Pharmaceuticals Business Overview
  52. 7.9.3 Arbor Pharmaceuticals Sotalol Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 7.9.4 Arbor Pharmaceuticals Sotalol Product Portfolio
  54. 7.9.5 Arbor Pharmaceuticals Recent Developments
8 North America
  1. 8.1 North America Sotalol Market Size by Type
  2. 8.1.1 North America Sotalol Revenue by Type (2021-2032)
  3. 8.1.2 North America Sotalol Sales by Type (2021-2032)
  4. 8.1.3 North America Sotalol Price by Type (2021-2032)
  5. 8.2 North America Sotalol Market Size by Application
  6. 8.2.1 North America Sotalol Revenue by Application (2021-2032)
  7. 8.2.2 North America Sotalol Sales by Application (2021-2032)
  8. 8.2.3 North America Sotalol Price by Application (2021-2032)
  9. 8.3 North America Sotalol Market Size by Country
  10. 8.3.1 North America Sotalol Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Sotalol Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Sotalol Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Sotalol Market Size by Type
  2. 9.1.1 Europe Sotalol Revenue by Type (2021-2032)
  3. 9.1.2 Europe Sotalol Sales by Type (2021-2032)
  4. 9.1.3 Europe Sotalol Price by Type (2021-2032)
  5. 9.2 Europe Sotalol Market Size by Application
  6. 9.2.1 Europe Sotalol Revenue by Application (2021-2032)
  7. 9.2.2 Europe Sotalol Sales by Application (2021-2032)
  8. 9.2.3 Europe Sotalol Price by Application (2021-2032)
  9. 9.3 Europe Sotalol Market Size by Country
  10. 9.3.1 Europe Sotalol Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Sotalol Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Sotalol Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Sotalol Market Size by Type
  2. 10.1.1 China Sotalol Revenue by Type (2021-2032)
  3. 10.1.2 China Sotalol Sales by Type (2021-2032)
  4. 10.1.3 China Sotalol Price by Type (2021-2032)
  5. 10.2 China Sotalol Market Size by Application
  6. 10.2.1 China Sotalol Revenue by Application (2021-2032)
  7. 10.2.2 China Sotalol Sales by Application (2021-2032)
  8. 10.2.3 China Sotalol Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Sotalol Market Size by Type
  2. 11.1.1 Asia Sotalol Revenue by Type (2021-2032)
  3. 11.1.2 Asia Sotalol Sales by Type (2021-2032)
  4. 11.1.3 Asia Sotalol Price by Type (2021-2032)
  5. 11.2 Asia Sotalol Market Size by Application
  6. 11.2.1 Asia Sotalol Revenue by Application (2021-2032)
  7. 11.2.2 Asia Sotalol Sales by Application (2021-2032)
  8. 11.2.3 Asia Sotalol Price by Application (2021-2032)
  9. 11.3 Asia Sotalol Market Size by Country
  10. 11.3.1 Asia Sotalol Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Sotalol Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Sotalol Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Sotalol Market Size by Type
  2. 12.1.1 SAMEA Sotalol Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Sotalol Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Sotalol Price by Type (2021-2032)
  5. 12.2 SAMEA Sotalol Market Size by Application
  6. 12.2.1 SAMEA Sotalol Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Sotalol Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Sotalol Price by Application (2021-2032)
  9. 12.3 SAMEA Sotalol Market Size by Country
  10. 12.3.1 SAMEA Sotalol Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Sotalol Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Sotalol Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Sotalol Value Chain Analysis
  2. 13.1.1 Sotalol Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Sotalol Production Mode & Process
  6. 13.2 Sotalol Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Sotalol Distributors
  9. 13.2.3 Sotalol Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.